MONOBACT 375MG INJECTION is a combination of Ceftriaxone and Sulbactam, which belongs to the group of medicines called Antibiotics. It is used in the management of infections of the brain (meningitis), lungs, middle ear, abdomen, and abdominal wall (peritonitis), urinary tract and kidneys, bones and joints, skin or soft tissues, blood, and heart.
MONOBACT 375MG INJECTION can also be used to manage specific sexually transmitted infections (gonorrhoea and syphilis), patients with low white blood cell counts (neutropenia) who have fever due to bacterial infection, Lyme disease (caused by tick bites), and infections during surgery.
MONOBACT 375MG INJECTION is not recommended for use in premature babies and new-born babies having
jaundice. Before receiving MONOBACT 375MG INJECTION, inform your doctor if you have liver or kidney diseases, colitis, hemolytic anemia, gallstones or kidney stones, upcoming surgeries, or pancreatitis.
MONOBACT 375MG INJECTION should be used with caution in pregnancy and breast feeding. Contact your doctor before receiving. MONOBACT 375MG INJECTION is not recommended for use in premature babies. Contact your child’s doctor. MONOBACT 375MG INJECTION should be used with caution in elderly patients (aged above 65 years or above). Contact your doctor before receiving.
The most common side effects of receiving MONOBACT 375MG INJECTION are diarrhea, rash, itching, pain at the site of injection, and inflammation of a vein caused by blood clots. Contact your doctor if any of the symptoms worsen.
No content available
